---
figid: PMC10867135__fphar-15-1355171-g002
figtitle: 'Glycaemic abnormalities induced by small molecule tryosine kinase inhibitors:
  a review'
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC10867135
filename: fphar-15-1355171-g002.jpg
figlink: /pmc/articles/PMC10867135/figure/F2
number: F2
caption: Schematic model of tumorigenic signaling pathways and their inhibition by
  anti-cancer- tyrosine kinase inhibitors
papertitle: 'Glycaemic abnormalities induced by small molecule tryosine kinase inhibitors:
  a review'
reftext: Takudzwa Mugiya, et al. Front Pharmacol. 2024;15(NA).
year: '2024'
doi: 10.3389/fphar.2024.1355171
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: diabetes mellitus | small molecule tyrosine kinase inhibitors | insulin
  resistance | blood glucose | cancer
automl_pathway: 0.9330703
figid_alias: PMC10867135__F2
figtype: Figure
redirect_from: /figures/PMC10867135__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10867135__fphar-15-1355171-g002.html
  '@type': Dataset
  description: Schematic model of tumorigenic signaling pathways and their inhibition
    by anti-cancer- tyrosine kinase inhibitors
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Imatinib
  - Dasatinib
  - Sunitinib
  - Axitinib
---
